UniProt ID | TRI39_HUMAN | |
---|---|---|
UniProt AC | Q9HCM9 | |
Protein Name | E3 ubiquitin-protein ligase TRIM39 | |
Gene Name | TRIM39 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 518 | |
Subcellular Localization | Cytoplasm, cytosol . Mitochondrion . Found predominantly in the cytosol. Partial shift from the cytosol to the mitochondria when colocalized with MOAP1. | |
Protein Description | E3 ubiquitin-protein ligase. May facilitate apoptosis by inhibiting APC/C-Cdh1-mediated poly-ubiquitination and subsequent proteasome-mediated degradation of the pro-apoptotic protein MOAP1.. | |
Protein Sequence | MAETSLLEAGASAASTAAALENLQVEASCSVCLEYLKEPVIIECGHNFCKACITRWWEDLERDFPCPVCRKTSRYRSLRPNRQLGSMVEIAKQLQAVKRKIRDESLCPQHHEALSLFCYEDQEAVCLICAISHTHRAHTVVPLDDATQEYKEKLQKCLEPLEQKLQEITRCKSSEEKKPGELKRLVESRRQQILREFEELHRRLDEEQQVLLSRLEEEEQDILQRLRENAAHLGDKRRDLAHLAAEVEGKCLQSGFEMLKDVKSTLEKNIPRKFGGSLSTICPRDHKALLGLVKEINRCEKVKTMEVTSVSIELEKNFSNFPRQYFALRKILKQLIADVTLDPETAHPNLVLSEDRKSVKFVETRLRDLPDTPRRFTFYPCVLATEGFTSGRHYWEVEVGDKTHWAVGVCRDSVSRKGELTPLPETGYWRVRLWNGDKYAATTTPFTPLHIKVKPKRVGIFLDYEAGTLSFYNVTDRSHIYTFTDTFTEKLWPLFYPGIRAGRKNAAPLTIRPPTDWE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
92 | Ubiquitination | GSMVEIAKQLQAVKR HHHHHHHHHHHHHHH | 58.14 | 21890473 | |
92 (in isoform 1) | Ubiquitination | - | 58.14 | 21890473 | |
92 | Ubiquitination | GSMVEIAKQLQAVKR HHHHHHHHHHHHHHH | 58.14 | 21890473 | |
92 (in isoform 2) | Ubiquitination | - | 58.14 | 21890473 | |
92 | Ubiquitination | GSMVEIAKQLQAVKR HHHHHHHHHHHHHHH | 58.14 | 21890473 | |
98 | Acetylation | AKQLQAVKRKIRDES HHHHHHHHHHHCCCC | 51.49 | 7492131 | |
147 | Phosphorylation | VVPLDDATQEYKEKL EEECCHHHHHHHHHH | 29.00 | 21214269 | |
150 | Phosphorylation | LDDATQEYKEKLQKC CCHHHHHHHHHHHHH | 18.03 | 21214269 | |
156 | Ubiquitination | EYKEKLQKCLEPLEQ HHHHHHHHHHHHHHH | 51.75 | - | |
277 | Phosphorylation | IPRKFGGSLSTICPR CCHHHCCCHHHCCCC | 21.37 | - | |
279 | Phosphorylation | RKFGGSLSTICPRDH HHHCCCHHHCCCCCH | 19.88 | - | |
280 | Phosphorylation | KFGGSLSTICPRDHK HHCCCHHHCCCCCHH | 31.71 | - | |
304 | Phosphorylation | NRCEKVKTMEVTSVS HCCCCCEEEEEEEEE | 22.88 | 28060719 | |
308 | Phosphorylation | KVKTMEVTSVSIELE CCEEEEEEEEEEEEH | 15.31 | 28060719 | |
309 | Phosphorylation | VKTMEVTSVSIELEK CEEEEEEEEEEEEHH | 21.02 | 28060719 | |
311 | Phosphorylation | TMEVTSVSIELEKNF EEEEEEEEEEEHHHC | 15.31 | 21815630 | |
385 | Phosphorylation | FYPCVLATEGFTSGR CCEEEEECCCCCCCC | 32.26 | - | |
422 (in isoform 2) | Ubiquitination | - | 59.55 | 21890473 | |
422 | Ubiquitination | SRKGELTPLPETGYW CCCCCEECCCCCCEE | 59.55 | 21890473 | |
439 | Phosphorylation | RLWNGDKYAATTTPF EEECCCCCEEECCCC | 13.25 | 16094384 | |
452 (in isoform 1) | Ubiquitination | - | 33.20 | 21890473 | |
452 | Ubiquitination | PFTPLHIKVKPKRVG CCCCEEEEECCCEEE | 33.20 | 21890473 | |
452 | Ubiquitination | PFTPLHIKVKPKRVG CCCCEEEEECCCEEE | 33.20 | 21890473 | |
468 | Phosphorylation | FLDYEAGTLSFYNVT EEEEECCEEEEEECC | 26.69 | 22461510 | |
472 | Phosphorylation | EAGTLSFYNVTDRSH ECCEEEEEECCCCCC | 12.83 | 22461510 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TRI39_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRI39_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRI39_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry."; Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.; Nat. Methods 2:591-598(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-439, AND MASSSPECTROMETRY. |